Insulin Delivery Devices Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Insulin Delivery Devices Market?
The insulin delivery devices market is anticipated to grow, fueled by the escalating occurrences of diabetes. Diabetes, a long-term disease distinguished by high levels of sugar in the blood, is primarily caused by either insufficient insulin production or the body’s inefficiency to use insulin effectively. The increase in diabetes is predominantly attributed to factors such as inactive lifestyles, poor eating habits, and the global surge in obesity. Insulin delivery devices play a vital role in assisting individuals with diabetes to regulate their blood sugar effectively. These devices allow for monitored and convenient administration of insulin, thereby averting complications and promoting general health. The Centers for Disease Control and Prevention, a US government agency, revealed in December 2022, that the count of young individuals under 20 with type 2 diabetes could escalate by nearly 700% by 2060 in the United States, potentially impacting 220,000 individuals. Concurrently, diagnoses of type 1 diabetes among young individuals could increase by up to 65%. Thus, the insulin delivery devices market expansion is being driven by the rising prevalence of diabetes.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp
#What is the Anticipated CAGR of theInsulin Delivery Devices Market, and What Factors Will Drive It?
The market size for insulin delivery devices has seen strong growth in the last few years, expanding from $17.71 billion in 2024 to an estimated $19.22 billion in 2025. This represents a compound annual growth rate (CAGR) of 8.5%. The historical growth pattern can be ascribed to several factors, including the convenience and simplicity of insulin delivery devices, favorable reimbursement policies, a rising incidence of obesity, an increasingly aging population, and a higher uptake of insulin pumps.
Strong expansion is anticipated in the insulin delivery devices market in the forthcoming years, with the market projected to reach a value of $26.3 billion by 2029, growing at an 8.2% compound annual growth rate (CAGR). The predicted growth during this period stems from the increasing number of diabetes patients, elevated spending on diabetes care, the emergence of continuous glucose monitoring systems, heightened patient awareness about the advantages of automated insulin delivery devices, and an intensified focus on healthcare. Notable forecast period trends encompass technological improvements in insulin delivery devices, incorporation of digital technology into these devices, the evolution of artificial pancreas systems, enhancements in insulin administration technology, and progress in bionic technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642
What Are the Key Market Innovations in theInsulin Delivery Devices Market Over the Coming Years?
Leading firms in the insulin delivery devices market are leveraging innovation to produce products like insulin pumps that deliver insulin in a continuous or customizable fashion. An insulin pump, a programmable medical device, delivers insulin on a continuous basis or as needed via a catheter inserted beneath the skin. For example, in May of 2023, Beta Bionics, an American medical tech company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and the iLet Dosing Decision Software. The iLet Bionic Pancreas system is meant to assist individuals aged six or older diagnosed with type 1 diabetes by merging two devices with an FDA-approved integrated continuous glucose monitor (iCGM). It is designed to function on an automated insulin dosing (AID) system controlled by an adaptive closed-loop algorithm that initially requires only the user’s body weight for setup and gets rid of the need for additional insulin dosing parameters. This system differs from traditional pump therapy as it doesn’t require manual adjustment of settings, thereby making it simpler to start and operate. The iLet device also introduces a feature that simplifies insulin dosing during meals by classifying meals as small, medium, or large. Over time, the algorithm learns and adjusts to individual insulin needs.
Who Are the Top Companies Driving Innovation and Growth in theInsulin Delivery Devices Market?
Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report
Which Key Market Segments Comprise the Insulin Delivery Devices Market and Drive Its Revenue Growth?
The insulin delivery devices market covered in this report is segmented –
1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps
7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps
8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp
Which Regions Are Emerging as Leaders in the Insulin Delivery Devices Market?
North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2025, By The Business Research Company:
Insulin biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024
Insulin Patch Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
